MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
48.00
-1.02 (-2.08%)
Oct 22, 2024, 4:00 PM EDT - Market closed

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $3.02 billion. The enterprise value is $2.51 billion.

Market Cap 3.02B
Enterprise Value 2.51B

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, before market open.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

MLTX has 62.89 million shares outstanding. The number of shares has increased by 49.62% in one year.

Shares Outstanding 62.89M
Shares Change (YoY) +49.62%
Shares Change (QoQ) +0.38%
Owned by Insiders (%) 14.14%
Owned by Institutions (%) 49.95%
Float 25.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 5.80
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 43.71, with a Debt / Equity ratio of 0.01.

Current Ratio 43.71
Quick Ratio 42.46
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -11.32% and return on invested capital (ROIC) is -9.49%.

Return on Equity (ROE) -11.32%
Return on Assets (ROA) -9.32%
Return on Capital (ROIC) -9.49%
Revenue Per Employee n/a
Profits Per Employee -$1.10M
Employee Count 50
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, MLTX has paid $222,184 in taxes.

Income Tax 222,184
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -12.71% in the last 52 weeks. The beta is 1.26, so MLTX's price volatility has been higher than the market average.

Beta (5Y) 1.26
52-Week Price Change -12.71%
50-Day Moving Average 49.36
200-Day Moving Average 47.73
Relative Strength Index (RSI) 45.17
Average Volume (20 Days) 420,805

Short Selling Information

The latest short interest is 7.97 million, so 12.68% of the outstanding shares have been sold short.

Short Interest 7.97M
Short Previous Month 7.77M
Short % of Shares Out 12.68%
Short % of Float 30.88%
Short Ratio (days to cover) 26.00

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -78.40M
Pretax Income -58.02M
Net Income -54.80M
EBITDA -78.35M
EBIT -78.40M
Earnings Per Share (EPS) -$0.92
Full Income Statement

Balance Sheet

The company has $519.80 million in cash and $3.34 million in debt, giving a net cash position of $516.46 million or $8.21 per share.

Cash & Cash Equivalents 519.80M
Total Debt 3.34M
Net Cash 516.46M
Net Cash Per Share $8.21
Equity (Book Value) 530.03M
Book Value Per Share 8.28
Working Capital 524.60M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$64.43 million and capital expenditures -$496,399, giving a free cash flow of -$64.93 million.

Operating Cash Flow -64.43M
Capital Expenditures -496,399
Free Cash Flow -64.93M
FCF Per Share -$1.03
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -49.62%
Shareholder Yield -49.62%
Earnings Yield -1.82%
FCF Yield -2.15%
Dividend Details

Analyst Forecast

The average price target for MLTX is $78.00, which is 62.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target $78.00
Price Target Difference 62.50%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a